Explore / Clinical trial
Clinical trial

The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers

AstraZenecaCompletedEarly Phase 1Started Feb 1, 201020 enrolledUnited StatesNCT00985933

Abstract

The purpose of this study is to assess if ketamine will induce, in healthy volunteers, impairment of working memory and if the drug AZD8529 will block the effects of ketamine on working memory as assessed by functional magnetic resonance imaging (fMRI).

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

Healthy normal volunteersHealthyMemory Impairment

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.